Generic drugs are cheaper for a number of reasons. The expiry of a patent allows free competition, which immediately lowers the price.
Many different companies can now produce the drug and compete to sell it, so they want to get the production costs and profit margins down as low as possible whilst still retaining profitability in order to undercut their rivals.
Patent holders on the other hand have huge expenses in developing a new drug so often place huge profit margins in order to make this money back before the patent runs out, they dont need to lower the price of their product as there is no competition as they are the only ones allowed to produce the drug.
There are often lower costs in developing and testing the drug for manufacture of generics as most of the hard work has already been done by the original developer and the company just has to prove to regulators their drug is bioequivalent and contains no harmful substances rather than go though lengthy clinical trials.
They also receive benefits of the previous patent holders marketing and often the drug is already well known by the medical profession making it easier to sell. The lower...
To view and download this full PLR article, you must be logged in. Registration is completely free. Once you create your account, you will be able to browse, search & downlod from our PLR articles database of over "1,57,897+" on 1,000's of niches and 200+ categories without paying a penny. Click here to signup...
